Wei Kang - Search Results

Year	Number of Results
2003	5
2004	4
2005	3
2006	2
2007	6
2008	1
2009	9
2010	6
2011	14
2012	19
2013	16
2014	20
2015	21
2016	24
2017	16
2018	40
2019	34
2020	45
2021	58
2022	68
2023	74
2024	16

1

Targeting m⁶A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.

Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, Huang D, Gou H, Chen D, Pan Y, Kang W, To KF, Yu J. Bao Y, et al. Among authors: kang w. Gut. 2023 Aug;72(8):1497-1509. doi: 10.1136/gutjnl-2022-328845. Epub 2023 Jan 30. Gut. 2023. PMID: 36717220 Free PMC article.

2

Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites.

Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, Zhao L, Li C, Zhou Y, Wang G, Kang W, Ng EK, Yu J. Bai X, et al. Among authors: kang w. Gut. 2022 Dec;71(12):2439-2450. doi: 10.1136/gutjnl-2021-325021. Epub 2022 Apr 6. Gut. 2022. PMID: 35387878 Free PMC article.

3

METTL3 Inhibits Antitumor Immunity by Targeting m⁶A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer.

Chen H, Pan Y, Zhou Q, Liang C, Wong CC, Zhou Y, Huang D, Liu W, Zhai J, Gou H, Su H, Zhang X, Xu H, Wang Y, Kang W, Kei Wu WK, Yu J. Chen H, et al. Among authors: kang w. Gastroenterology. 2022 Oct;163(4):891-907. doi: 10.1053/j.gastro.2022.06.024. Epub 2022 Jun 11. Gastroenterology. 2022. PMID: 35700773 Free article.

4

ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy.

Zhai J, Chen H, Wong CC, Peng Y, Gou H, Zhang J, Pan Y, Chen D, Lin Y, Wang S, Kang W, To KF, Chen Z, Nie Y, He HH, Sung JJ, Yu J. Zhai J, et al. Among authors: kang w. Gastroenterology. 2023 Aug;165(2):445-462. doi: 10.1053/j.gastro.2023.04.032. Epub 2023 May 9. Gastroenterology. 2023. PMID: 37169182 Free article.

5

N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.

Wang S, Gao S, Zeng Y, Zhu L, Mo Y, Wong CC, Bao Y, Su P, Zhai J, Wang L, Soares F, Xu X, Chen H, Hezaveh K, Ci X, He A, McGaha T, O'Brien C, Rottapel R, Kang W, Wu J, Zheng G, Cai Z, Yu J, He HH. Wang S, et al. Among authors: kang w. Gastroenterology. 2022 Apr;162(4):1183-1196. doi: 10.1053/j.gastro.2021.12.269. Epub 2021 Dec 28. Gastroenterology. 2022. PMID: 34968454 Free article.

6

Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.

Li C, Wang Y, Liu D, Wong CC, Coker OO, Zhang X, Liu C, Zhou Y, Liu Y, Kang W, To KF, Sung JJ, Yu J. Li C, et al. Among authors: kang w. Gut. 2022 Nov;71(11):2253-2265. doi: 10.1136/gutjnl-2021-325851. Epub 2022 Mar 1. Gut. 2022. PMID: 35232776 Free PMC article.

7

Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase.

Li Q, Hu W, Liu WX, Zhao LY, Huang D, Liu XD, Chan H, Zhang Y, Zeng JD, Coker OO, Kang W, Ng SSM, Zhang L, Wong SH, Gin T, Chan MTV, Wu JL, Yu J, Wu WKK. Li Q, et al. Among authors: kang w. Gastroenterology. 2021 Mar;160(4):1179-1193.e14. doi: 10.1053/j.gastro.2020.09.003. Epub 2020 Sep 11. Gastroenterology. 2021. PMID: 32920015

8

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.

Zhou Q, Peng Y, Ji F, Chen H, Kang W, Chan LS, Gou H, Lin Y, Huang P, Chen D, Wei Q, Su H, Liang C, Zhang X, Yu J, Wong CC. Zhou Q, et al. Among authors: kang w. Nat Commun. 2023 Aug 4;14(1):4677. doi: 10.1038/s41467-023-39571-6. Nat Commun. 2023. PMID: 37542037 Free PMC article.

9

The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas.

Chen B, Chan WN, Xie F, Mui CW, Liu X, Cheung AHK, Lung RWM, Chow C, Zhang Z, Fang C, Yu P, Shi S, Zhou S, Chen G, Wang Z, Wang S, Ding X, Huang B, Liang L, Dong Y, Wong CC, Wu WKK, Cheng ASL, Wong N, Yu J, Lo KW, Tse GMK, Kang W, To KF. Chen B, et al. Among authors: kang w. Clin Transl Med. 2023 Dec;13(12):e1516. doi: 10.1002/ctm2.1516. Clin Transl Med. 2023. PMID: 38148640 Free PMC article.

10

The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer.

Wong CC, Wu JL, Ji F, Kang W, Bian X, Chen H, Chan LS, Luk STY, Tong S, Xu J, Zhou Q, Liu D, Su H, Gou H, Cheung AH, To KF, Cai Z, Shay JW, Yu J. Wong CC, et al. Among authors: kang w. Nat Commun. 2022 Jul 8;13(1):3971. doi: 10.1038/s41467-022-31663-z. Nat Commun. 2022. PMID: 35803966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

437 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Results by year